European Journal of Oncology Pharmacy

ISSN 1783-3914Lippincott Williams and WilkinsBelgium
ScopusMEDLINEEmbaseSCImagoMatched via identifier

Journal overview

Titles
European Journal of Oncology Pharmacy
Eur. J. Oncolog. Pharm. (abbreviated)
ISSN
1783-3914
eISSN
2032-7072
NLM ID
Not available
Publisher
Lippincott Williams and Wilkins
Country
Language
ENG

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2017–2026, 2008–2015
Indexing services (MEDLINE, Embase)
MEDLINEUnknownEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
Not available
Full-text availability (PMC — not an indexing service)
Not available

Metrics

JIF
Not available
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.211
Best Quartile
Q4
H-index
7
Subject categories
  • Oncology — Q4
  • Pharmacology — Q4
More metrics
Coverage
2008–2015, 2017–2025
Country
Belgium
Region
Western Europe
Publisher
Lippincott Williams and Wilkins
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
1
Total documents (3 years)
19
Total references
39
Total citations (3 years)
17
Citable documents (3 years)
18
Citations per document (2 years)
1.14
References per document
39
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
2032-7072, 1783-3914
SCImago Source ID
19700174992
SCImago Rank (across all SCImago source types)
21264

Publication activity

Publication activity
2025
1 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Not available
Scopus:2017-2026; 2008-2015